Aralez Bio is a biopharmaceutical company pioneering a platform that unlocks an unprecedented range of noncanonical amino acids (also known as unnatural or unusual amino acids). These noncanonical amino acids can modify the properties of biomolecules, allowing for tailored products to meet specific customer needs. They are essential for developing next-generation products with exceptional chemical, biological, and physical properties.
By utilizing enzymes, Aralez Bio has achieved a technological breakthrough that is efficient, scalable, and sustainable, pushing the boundaries of bio-based product development. The company's offerings include Tryptophan Analogs, Tyrosine Analogs, D-Isomer Modifications, and N-Methyl Modifications. These innovations are applicable across pharmaceuticals, agriculture, and functional materials, driving sustainable advancements in these fields.
